The Hague: The Pfizer / Biotech Corona virus job was allowed on Thursday to feed children between the ages of five and 11 in Europe, clearing the way for vaccinations in a group where the virus is spreading rapidly.
The European Medicines Agency (EMA) said a panel of experts had recommended extending the indication for the use of the COVID-19 vaccine Comirnaty in children aged five to 11 years.
The vaccine has already been cleared for use in people aged 12 and over in the 27-nation European Union.
Pfizer’s job has so far only been approved in a few countries, including the United States, Israel and Canada, for children aged five to 11.
The EMA said children between the ages of five and 11 will receive one-third of the dose that adults receive, with two injections, every three weeks.
He added that the vaccine was 90.7% effective in a study of about 2,000 children of that age. Side effects were usually “mild or moderate” lasting for a few days, and included pain, fatigue, headache, muscle aches, and chills at the injection site.
The EMA therefore “concluded that the benefits of Comirnaty outweigh the risks in children between the ages of five and 11, especially in situations that increase the risk of severe Covid-19.”
In the Netherlands, where the EMA is based, officials said earlier this week that the highest increase in cases was among children up to 12 years old.
The regulator has so far approved four vaccines for use in the EU: Pfizer and Moderna, which use Messenger RNA technology, and AstraZeneca and Johnson & Johnson, which use viral vector technology.